Molecular mechanisms underlying inherited photoreceptor degeneration as targets for therapeutic intervention

Front Cell Neurosci. 2024 Feb 2:18:1343544. doi: 10.3389/fncel.2024.1343544. eCollection 2024.

Abstract

Retinitis pigmentosa (RP) is a form of retinal degeneration characterized by primary degeneration of rod photoreceptors followed by a secondary cone loss that leads to vision impairment and finally blindness. This is a rare disease with mutations in several genes and high genetic heterogeneity. A challenging effort has been the characterization of the molecular mechanisms underlying photoreceptor cell death during the progression of the disease. Some of the cell death pathways have been identified and comprise stress events found in several neurodegenerative diseases such as oxidative stress, inflammation, calcium imbalance and endoplasmic reticulum stress. Other cell death mechanisms appear more relevant to photoreceptor cells, such as high levels of cGMP and metabolic changes. Here we review some of the cell death pathways characterized in the RP mutant retina and discuss preclinical studies of therapeutic approaches targeting the molecular outcomes that lead to photoreceptor cell demise.

Keywords: ER-stress; cGMP; calcium; inflammation; oxidative stress; rhodopsin.

Publication types

  • Review

Grants and funding

The authors declare financial support was received for the research, authorship, and/or publication of this article. The Marigo’s research group is supported by Fondazione Telethon grant GGP19113, JTC2020 TreatRP, PIANO NAZIONALE DI RIPRESA E RESILIENZA (PNRR) —- MISSIONE 4 “Istruzione Ricerca” COMPONENTE 2, “Dalla ricerca all’impresa” INVESTIMENTO 1.4, “Potenziamento strutture di ricerca e creazione di ‘campioni nazionali di R&S’ su alcune Key enabling technologies,” finanziato dall’Unione europea—NextGenerationEU “National Center for Gene Therapy and Drugs based on RNA Technology” cod. Progetto CN00000041 (2022-2025) and PIANO NAZIONALE DI RIPRESA E RESILIENZA (PNRR) —- MISSIONE 4 “Istruzione Ricerca” COMPONENTE 2, “Dalla ricerca all’impresa” INVESTIMENTO 1.4, “Potenziamento strutture di ricerca e creazione di ‘campioni nazionali di R&S’ su alcune Key enabling technologies,” finanziato dall’Unione europea—NextGenerationEU Paternariato Esteso HEAL ITALIA (2022-2025), PRIN 2022–Piano Nazionale di Ripresa e Resilienza a titolarità del Ministero dell’Università e della Ricerca (2022R9BKZN).